4//SEC Filing
Patel Paresh 4
Accession 0001209191-19-019380
CIK 0001400810other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 3:40 PM ET
Size
16.6 KB
Accession
0001209191-19-019380
Insider Transaction Report
Form 4
Patel Paresh
DirectorExecutive Chairman
Transactions
- Purchase
Common stock
2019-03-13$41.20/sh+7,000$288,393→ 447,000 total
Holdings
- 20,000
Common Stock
- 40,000
Common Stock
- 103,000
Common Stock
- 300,000
Common stock
- 30,000
Common Stock
- 110,000
Stock Option (Right to Buy)
Exercise: $40.00Exp: 2028-02-08→ Common (110,000 underlying) - 35,000(indirect: By IRA)
Common stock
- 110,000
Stock Option (Right to Buy)
Exercise: $40.00Exp: 2027-01-07→ Common (110,000 underlying) - 110,000
Stock Option (Right to Buy)
Exercise: $53.00Exp: 2029-01-15→ Common (110,000 underlying)
Footnotes (10)
- [F1]Restricted stock grant of 400,000 shares effective 5/16/2013: the Issuer cancelled effective 3/2/2016 a 100,000 share tranche of this grant that was to have vested one year after the closing price of HCI common shares equaled or exceeded $50 per share for 20 consecutive trading days. Of the award's 300,000 remaining shares, 100,000 have previously vested, 100,000 shares will vest one year after the closing price of HCI common shares equals or exceeds $65 per share for 20 consecutive trading days, and 100,000 will vest one year after the closing price of HCI common shares equals or exceeds $80 per share for 20 consecutive trading days. All shares for which restrictions have not lapsed 6 years and one day from the grant date will be forfeited. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 5/16/2013.
- [F10]The options were granted on January 15, 2019 at an exercise price of $53.00 per share, in excess of the $47.94 market value. Commencing on January 15, 2020 and continuing on the same day of each calendar year thereafter through and including January 15, 2023, the amount of 27,500 options will vest and become exercisable on each such annual vesting date. Once vested, the options may be exercised at any time up to and including January 15, 2029.
- [F2]The reported price in Column 4 is a weighted average price. The shares were purchased in two transactions at prices of $41.1739 and $41.2184. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price set forth in this footnote.
- [F3]Shares held jointly with spouse.
- [F4]Restricted stock grant of 40,000 shares effective January 7, 2017: Restrictions on 20,000 shares have lapsed. Restrictions on the remaining 20,000 shares will lapse in 10,000 amounts on each of January 7, 2020 and January 7, 2021. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock award contract dated January 7, 2017.
- [F5]Restricted stock grant of 40,000 shares effective February 8, 2018: Restrictions on 10,000 shares have lapsed. Restrictions on the remaining 30,000 shares will lapse in 10,000 amounts on each of February 8, 2020, February 8, 2021, and February 8, 2022. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock award contract dated February 8, 2018.
- [F6]Restricted stock grant of 40,000 shares effective January 15, 2019: Restrictions on 10,000 shares will lapse on each of January 15, 2020, January 15, 2021, January 15, 2022, and January 15, 2023. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock award contract dated January 15, 2019.
- [F7]The options were granted pursuant to the HCI Group, Inc. 2012 Omnibus Incentive Plan.
- [F8]The options were granted on January 7, 2017 at an exercise price of $40.00 per share, in excess of the $39.71 market value. Commencing on January 7, 2018 and continuing on the same day of each calendar year thereafter through and including January 7, 2021, the amount of 27,500 options will vest and become exercisable on each such annual vesting date. Once vested, the options may be exercised at any time up to and including January 7, 2027.
- [F9]The options were granted on February 8, 2018 at an exercise price of $40.00 per share, in excess of the $34.92 market value. Commencing on February 8, 2019 and continuing on the same day of each calendar year thereafter through and including February 8, 2022, the amount of 27,500 options will vest and become exercisable on each such annual vesting date. Once vested, the options may be exercised at any time up to and including February 8, 2028.
Documents
Issuer
HCI Group, Inc.
CIK 0001400810
Entity typeother
Related Parties
1- filerCIK 0001439934
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 3:40 PM ET
- Size
- 16.6 KB